— Expedia Group, Inc. (NASDAQ: EXPE) Wednesday reported adjusted earnings of $3.38 per share for the third quarter, vs. $3.8 per share expected.
— Net income was $409 million or $2.71 per share, compared to $525 million or $3.43 per share a year earlier.
— Third-quarter revenues climbed to $3.6 billion from $3.3 billion a year earlier, vs. $3.58 billion expected
— Gross bookings increased 9% annually to $26.9 billion; total stayed lodging room nights increased 11%
— Exceeded 1.4 million properties available on the core lodging platform as of September
— Adjusted EBITDA was flat at $912 million in the third quarter
Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated
The healthcare sector is going through a phase of consolidation, creating fresh opportunities for emerging companies in a market that is slowly recovering from the pandemic. Several pharmaceuticals firms have
Shares of American Airlines Group (NASDAQ: AAL) have gained 42% since the beginning of this year and 50% over the past 12 months. Despite this, there is a mixed sentiment